A new study published in the journal of BMC Pulmonary Medicine showed that 10% of psoriasis patients would have interstitial ...

Zasocitinib is under clinical development by Takeda Pharmaceutical and currently in Phase I for Systemic Lupus Erythematosus.

Secukinumab is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Psoriasis is a chronic inflammatory disease of the immune system that develops when the body makes skin cells too quickly, causing skin cells to pile up and form visible patches or spots on the skin.

Research has found that arachidonic acid can create chemicals that cause inflammation, which may worsen the red, scaly patches seen in psoriasis. Celiac disease is a health condition characterized ...

Psoriasis is a chronic autoimmune disease in which the body's immune system attacks skin cells with inflammation, causing them to multiply faster than they can be shed. This causes the cells to pile ...

There are more than 10 common skin diseases seen in adults, such as acne, atopic dermatitis (eczema), cold sores, hives, and psoriasis. It can be difficult to identify these skin problems by ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

This is a valuable study regarding the role of gasdesmin D in experimental psoriasis. The study contains solid evidence for such a role, involving neutrophils, from murine models of skin inflammation, ...

Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the ...

Oral retinoids are often used to treat pustular psoriasis ... You have serious liver or kidney disease. You have high triglycerides. Systemic biologic psoriasis treatments These are newer drugs ...